Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Constrictive pericarditis

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Rapidly worsening low output, severe congestion with renal/hepatic failure, or diagnostic concern for effusive-constrictive tamponade requires urgent admission and specialist haemodynamic assessment.

Synopsis

Distinguish potentially curable pericardial constriction from restrictive myocardium, identify transient inflammation and refer fixed disease for timely pericardiectomy.

  • Constrictive pericarditis is impaired diastolic filling from a non-compliant pericardium and is a potentially curable cause of predominantly right-sided HF.
  • Clues are raised JVP, prominent y descent, Kussmaul sign, pericardial knock, ascites and oedema with relatively clear lungs.
  • Echo looks for ventricular interdependence: septal bounce, respiratory mitral/tricuspid inflow variation and expiratory hepatic-vein diastolic reversal.
  • Medial mitral e-prime is often preserved or increased and may exceed lateral e-prime ('annulus reversus'), unlike myocardial restriction.
  • CT defines calcification and thickness; CMR identifies inflammation—but normal thickness does not exclude physiological constriction.
  • Inflammatory transient constriction may resolve with cause-specific/anti-inflammatory therapy and serial imaging.
  • Complete pericardiectomy is definitive for persistent symptomatic fixed constriction; refer before cachexia, cirrhosis or severe end-organ dysfunction.
  • Diuretics relieve congestion but excessive preload reduction can lower output and should not postpone surgical assessment.

Key red flags

Advanced disease

Hypotension, hyponatraemia, renal dysfunction, jaundice/cardiac cirrhosis, severe hypoalbuminaemia or cachexia signals high operative risk and urgent referral.

Effusive-constrictive disease

Persistently elevated right-sided pressure after pericardial drainage suggests visceral-pericardial constriction and needs expert haemodynamic review.

Investigation priorities

01
Comprehensive Doppler TTEFirst step

Demonstrate interdependence and distinguish constriction from restriction.

Management branches

DiagnosisSuspected constrictive physiology

Unexplained right HF/HFpEF with pericardial risk or JVP signs.

  1. Obtain expert Doppler echo and review prior surgery, radiation, pericarditis, TB and malignancy; assess liver/renal/nutritional status.
  2. Use CT for thickness/calcification and CMR for inflammation, interdependence and myocardial differential.
  3. If echo/CMR are discordant or restriction remains plausible, perform simultaneous left/right haemodynamics at an experienced centre.
  4. Classify as transient inflammatory, chronic fixed, effusive-constrictive or mixed myocardial-pericardial disease before choosing therapy.

Key medicines

FurosemideCommon oral starting dose 20-40 mg once daily, titrated cautiously to congestion.Constriction is preload-dependent; overdiuresis can cause low output, hypotension, renal injury and hyponatraemia. It is not definitive treatment.
Ibuprofen600 mg orally three times daily for active inflammatory constriction, then taper after clinical and CRP remission; maximum 2400 mg/day.Do not use for fixed non-inflammatory constriction. Renal, GI, bleeding, HF and pregnancy risks require review.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • 2025 ESC Guidelines for myocarditis and pericarditisCurrent constriction classification, imaging and treatment framework.
  • ESC: Constrictive pericarditis—role of echo and CMRRespiratory physiology and restrictive differential.
  • ESC: Constrictive pericarditis—prevention and treatmentPericardiectomy and cause-directed therapy.
  • ESC: Constrictive pericarditis—prevalence, causes and presentationRisk history, JVP and clinical differentiation.
  • Ibuprofen 600 mg SmPCDose ceiling and NSAID safety.
  • Colchicine 250 micrograms/mL oral solution SmPCExact adult weight-based dose and renal, hepatic and interaction safeguards; use for constrictive physiology itself remains specialist-led.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom